{"id":9186,"date":"2020-04-04T10:11:43","date_gmt":"2020-04-04T09:11:43","guid":{"rendered":"https:\/\/biomimexpo.com\/?p=9186"},"modified":"2021-02-22T15:14:22","modified_gmt":"2021-02-22T14:14:22","slug":"corwave","status":"publish","type":"post","link":"https:\/\/biomimexpo.com\/en\/2020\/04\/04\/corwave\/","title":{"rendered":"CORWAVE"},"content":{"rendered":"
\n
<\/div>\n
\n

\"\"<\/a><\/p>\n

https:\/\/biomimexpo.com\/wp-content\/uploads\/2020\/04\/Video-produit-CorWave_CorWave-product-video.mp4<\/a><\/video><\/div>\n

CorWave develops innovative implantable cardiac pumps based on a breakthrough technology: the undulating membrane.<\/p>\n

The CorWave corrugated membrane offers a novel approach in cardiac assist to provide true pulsatile blood flow.<\/p>\n

CorWave is a fast-growing medical device company that develops novel cardiac assist pumps to provide\u00a0reliable and sustainable solution<\/strong>\u00a0to the major public health issue ofheart failure<\/strong>. The solutions developed by CorWave, which are truly physiological, will ensure\u00a0better life<\/strong>\u00a0to patients.<\/p>\n

Founded in 2011 by the incubator\u00a0MD Start<\/strong>\u00a0and supported by renowned investors, CorWave has obtained\u00a0over \u20ac35 million in funding<\/strong>\u00a0and employs more than\u00a050 employees.<\/strong><\/p>\n

CorWave has won numerous awards and competitions. In 2016 CorWave won phase 1 of the Global Innovation Contest (GIC) for the NovaPulse project. In 2017, this project also won phase 2 of the CMI competition. The same year, CorWave received the Deloitte Technology Fast 50 Biotech of the Future award, and in 2018 received support for the Calypso programme under the Programme d'Investissements d'Avenir (PIA) operated by Bpifrance.<\/p>\n<\/div>\n<\/div>\n

\n

Videos :<\/span><\/strong><\/p>\n